Page last updated: 2024-08-21

evans blue and natriuretic peptide, brain

evans blue has been researched along with natriuretic peptide, brain in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, H; Garbers, DL; Hamanaka, I; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Mochizuki, S; Nakao, K; Saito, Y; Takahashi, N; Takemura, G1

Other Studies

1 other study(ies) available for evans blue and natriuretic peptide, brain

ArticleYear
Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:2

    Topics: Animals; Atrial Natriuretic Factor; Binding Sites, Antibody; Blotting, Western; Evans Blue; Guanylate Cyclase; Heart Ventricles; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Natriuretic Peptide, Brain; Neutrophils; NF-kappa B; P-Selectin; Peroxidase; Polysaccharides; Receptors, Atrial Natriuretic Factor; Signal Transduction; Time Factors; Up-Regulation

2001